BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 17133503)

  • 21. Noninvasive markers of fibrosis and inflammation in clinical practice: prospective comparison with liver biopsy.
    Anastasiou J; Alisa A; Virtue S; Portmann B; Murray-Lyon I; Williams R
    Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):474-80. PubMed ID: 19887952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of fibrosis by transient elastography compared with liver biopsy and morphometry in chronic liver diseases.
    Wong GL; Wong VW; Choi PC; Chan AW; Chum RH; Chan HK; Lau KK; Chim AM; Yiu KK; Chan FK; Sung JJ; Chan HL
    Clin Gastroenterol Hepatol; 2008 Sep; 6(9):1027-35. PubMed ID: 18456573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transient elastography: a valid alternative to biopsy in patients with chronic liver disease.
    Gómez-Domínguez E; Mendoza J; Rubio S; Moreno-Monteagudo JA; García-Buey L; Moreno-Otero R
    Aliment Pharmacol Ther; 2006 Aug; 24(3):513-8. PubMed ID: 16886917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver stiffness measurement versus clinicians' prediction or both for the assessment of liver fibrosis in patients with chronic hepatitis C.
    Nahon P; Thabut G; Ziol M; Htar MT; Cesaro F; Barget N; Grando-Lemaire V; Ganne-Carrie N; Trinchet JC; Beaugrand M
    Am J Gastroenterol; 2006 Dec; 101(12):2744-51. PubMed ID: 17227522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A meta-analysis of transient elastography for the detection of hepatic fibrosis.
    Stebbing J; Farouk L; Panos G; Anderson M; Jiao LR; Mandalia S; Bower M; Gazzard B; Nelson M
    J Clin Gastroenterol; 2010 Mar; 44(3):214-9. PubMed ID: 19745758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).
    Yoneda M; Yoneda M; Mawatari H; Fujita K; Endo H; Iida H; Nozaki Y; Yonemitsu K; Higurashi T; Takahashi H; Kobayashi N; Kirikoshi H; Abe Y; Inamori M; Kubota K; Saito S; Tamano M; Hiraishi H; Maeyama S; Yamaguchi N; Togo S; Nakajima A
    Dig Liver Dis; 2008 May; 40(5):371-8. PubMed ID: 18083083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease.
    Wong VW; Vergniol J; Wong GL; Foucher J; Chan HL; Le Bail B; Choi PC; Kowo M; Chan AW; Merrouche W; Sung JJ; de Lédinghen V
    Hepatology; 2010 Feb; 51(2):454-62. PubMed ID: 20101745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan®.
    de Lédinghen V; Wong VW; Vergniol J; Wong GL; Foucher J; Chu SH; Le Bail B; Choi PC; Chermak F; Yiu KK; Merrouche W; Chan HL
    J Hepatol; 2012 Apr; 56(4):833-9. PubMed ID: 22173167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of liver fibrosis and cirrhosis by transient elastography among patients with chronic HBV and HCV infection in Georgia.
    Tsertsvadze T; Dolmazashvili E; Abutidze A; Sharvadze L; Karchava M
    Georgian Med News; 2008 Dec; (165):38-42. PubMed ID: 19124915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease.
    Nahon P; Kettaneh A; Tengher-Barna I; Ziol M; de Lédinghen V; Douvin C; Marcellin P; Ganne-Carrié N; Trinchet JC; Beaugrand M
    J Hepatol; 2008 Dec; 49(6):1062-8. PubMed ID: 18930329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The optimal cut-off for predicting large oesophageal varices using transient elastography is disease specific.
    Pritchett S; Cardenas A; Manning D; Curry M; Afdhal NH
    J Viral Hepat; 2011 Apr; 18(4):e75-80. PubMed ID: 21040236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical factors associated with liver stiffness in hepatitis B e antigen-positive chronic hepatitis B patients.
    Wong GL; Wong VW; Choi PC; Chan AW; Chim AM; Yiu KK; Chan HY; Chan FK; Sung JJ; Chan HL
    Clin Gastroenterol Hepatol; 2009 Feb; 7(2):227-33. PubMed ID: 19121647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B.
    Kim BK; Kim SA; Park YN; Cheong JY; Kim HS; Park JY; Cho SW; Han KH; Chon CY; Moon YM; Ahn SH
    Liver Int; 2007 Sep; 27(7):969-76. PubMed ID: 17696936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis.
    Lemoine M; Katsahian S; Ziol M; Nahon P; Ganne-Carrie N; Kazemi F; Grando-Lemaire V; Trinchet JC; Beaugrand M
    Aliment Pharmacol Ther; 2008 Nov; 28(9):1102-10. PubMed ID: 18691352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of transient elastometry to differentiate mild from moderate to severe liver fibrosis in HIV/HCV co-infected patients.
    Macías J; Recio E; Vispo E; Rivero A; López-Cortés LF; Ríos MJ; Merino D; González M; Barreiro P; de Lédinghen V; Quereda C; Pineda JA
    J Hepatol; 2008 Dec; 49(6):916-22. PubMed ID: 18929426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.
    Dinesen L; Caspary WF; Chapman RW; Dietrich CF; Sarrazin C; Braden B
    Dig Liver Dis; 2008 Sep; 40(9):743-8. PubMed ID: 18339592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved diagnostic accuracy of blood tests for severe fibrosis and cirrhosis in chronic hepatitis C.
    Boursier J; Bacq Y; Halfon P; Leroy V; de Ledinghen V; de Muret A; Bourlière M; Sturm N; Foucher J; Oberti F; Rousselet MC; Calès P
    Eur J Gastroenterol Hepatol; 2009 Jan; 21(1):28-38. PubMed ID: 19060630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation.
    Poynard T; Halfon P; Castera L; Charlotte F; Le Bail B; Munteanu M; Messous D; Ratziu V; Benhamou Y; Bourlière M; De Ledinghen V;
    Aliment Pharmacol Ther; 2007 Mar; 25(6):733-9. PubMed ID: 17311607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic fibrosis scan for liver stiffness score measurement: a useful preendoscopic screening test for the detection of varices in postoperative patients with biliary atresia.
    Chang HK; Park YJ; Koh H; Kim SM; Chung KS; Oh JT; Han SJ
    J Pediatr Gastroenterol Nutr; 2009 Sep; 49(3):323-8. PubMed ID: 19633573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decision-making model for a non-invasive diagnosis of compensated liver cirrhosis.
    Marmo R; Romano M; de Sio I; Peduto A; Caporaso N; Persico M; Coltorti M
    Ital J Gastroenterol; 1993 Jan; 25(1):1-8. PubMed ID: 8428017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.